Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04283097
Recruitment Status : Recruiting
First Posted : February 25, 2020
Last Update Posted : June 8, 2021
Sponsor:
Information provided by (Responsible Party):
Kangpu Biopharmaceuticals, Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 30, 2022
Estimated Study Completion Date : December 30, 2022